Tirzepatide is a dual incretin receptor agonist, meaning it activates both the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
Conclusion: Your Path to a Healthier You Achieving sustainable weight loss often requires a multifaceted approach
It was an unexpected result, and one that caught the public's and Hollywood's eye
Briefly, 24-hour EE and related components [sleeping metabolic rate (SMR)- primary endpoint
It increases intracellular water content in muscle cells, creating a more anabolic environment
By inhibiting CYP3A4, macrolide antibitiotics, such as erythromycin and clarithromycin, but not azithromycin, can significantly increase the AUC of the drugs that depend on it for clearance, which can lead to higher risk of adverse effects or drug-drug interactions